Close Menu
December 05, 2018
Sponsored by
Agena Bioscience

Validating a Diagnostic Mass Spec Platform for a Molecular Pathology Service Lab


Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This webinar will describe how a molecular pathology laboratory selected and validated a mass spectrometry-based analysis platform for diagnostic use.

Doug Demetrick, director of the Molecular Pathology Laboratory at Calgary Laboratory Services, will share his experience implementing the Agena MassArray platform in his lab.

This presentation will focus on the Agena iPLEX HS chemistry, which enables solid tumor profiling in lung, colon, melanoma, and brain samples. Dr. Demetrick will also discuss his ongoing work to enable liquid biopsy using the Agena UltraSeek chemistry.

Sponsored by

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.